D3-Pharmacy Aps: Financial statements 2017
CVR: 71087611
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
D3-Pharmacy Aps (CVR 71087611) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 235,663 and a net result of DKK -116,314 compared with DKK 129,798 the year before. That is an increase of 22.6% compared with the year before. Equity in the 2017 report amounted to DKK 610,785. The solvency ratio was 44.9%.
- Gross Profit
- DKK 235,663
- Profit/Loss
- DKK -116,314
- Equity
- DKK 610,785
- Total Assets
- DKK 1,360,785
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 236 t. | -116 t. | 611 t. | - |
| 2016 | - | 192 t. | 130 t. | 727 t. | - |
| 2015 | - | 107 t. | 65 t. | 697 t. | - |
| 2014 | - | 189 t. | 104 t. | 632 t. | - |
| 2013 | - | 117 t. | 32 t. | 528 t. | - |
Keep an eye on D3-Pharmacy Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
D3-Pharmacy Aps has published its annual report for 2016. Gross profit came to DKK 192,293, and the net result was DKK 129,798.
As of February 28, 2017, ONREVISION, REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of D3-Pharmacy Aps.
About D3-Pharmacy Aps
D3-Pharmacy Aps is a Danish company of the type Anpartsselskab based in Svenstrup J, founded in 1982. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Finn Jørgen Jensen. The company is owned by Finn Jørgen Jensen. According to the 2023 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147.